Search clinical trials for: mAb Nimotuzumab

Total 1832 results

Air Force Military Medical University, China

Recruiting

GNT Induction Treatment in Locally Advanced NPC

Nasopharyngeal Carcinoma

China
YM BioSciences

Completed

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

Recurrent Diffuse Pontine Gliomas

United States, Canada, Israel
TORL Biotherapeutics, LLC
Translational Research in Oncology

Recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

Gastric Cancer | Advanced Solid Tumor | Pancreas Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, United States
Peking University
Chinese PLA General Hospital

Unknown

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma (NIEGA)

Stomach Neoplasms

China
Fudan University

Not yet recruiting

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Pancreatic Neuroendocrine Neoplasm

China
Eye & ENT Hospital of Fudan University

Not yet recruiting

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

Head and Neck Squamous Cell Carcinoma

China
Gilead Sciences

Terminated

Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) (ATLAS)

Idiopathic Pulmonary Fibrosis

United States
Biotech Pharmaceutical Co., Ltd.

Terminated

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

China
YM BioSciences

Terminated

Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer

Colorectal Cancer

Canada
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Esophageal

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial People... and other collaborators

Recruiting

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Nasopharyngeal Diseases | Head and Neck Neoplasm

China
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Sun Yat-sen University; Jiangxi Provincial Cancer Hospital and other collaborators

Unknown

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma

China
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...

Completed

Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Esophageal Cancer

China
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Advanced Esophageal

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Yonsei University

Completed

Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer (DATE)

Non Small Cell Lung Cancer (NSCLC)

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Shanghai Junshi Bioscience Co., Ltd.

Terminated

A Phase I Study of JS108 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
GlaxoSmithKline

Terminated

Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging

Amyloidosis

Sweden
Novartis Pharmaceuticals

Withdrawn

Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia (OBERON)

Acute Lymphoblastic Leukemia
Kyverna Therapeutics

Not yet recruiting

A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
Zhejiang Cancer Hospital

Unknown

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma Resectable

China
Ruijin Hospital

Completed

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Resectable Pancreatic Cancer
Eurofarma Laboratorios S.A.
Centro de Immunologia Molecular, Cuba

Completed

Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma (POLARIS)

Diffuse Intrinsic Brainstem Gliomas

Brazil, Cuba
Zhejiang University

Withdrawn

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Squamous Cell Carcinoma of Esophagus

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer (NOTABLE-308)

Refractory Metastatic Colorectal Cancer
Gilead Sciences

Completed

Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis

Myelofibrosis

United States
Sun Yat-sen University

Active, not recruiting

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Samsung Medical Center

Unknown

Afatinib Plus Nimotuzumb for NSCLC

NSCLC

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Nasopharyngeal Cancer

China
Oncoscience AG
University of Kiel; Marienhospital Herne; Gemeinschaftspraxis für Hämatologie... and other collaborators

Completed

Nimotuzumab in Adults With Pancreatic Cancer

Pancreatic Cancer, Advanced or Metastatic

Germany
Jiangxi Provincial Cancer Hospital

Recruiting

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Pfizer
UCB Pharma

Completed

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Lymphoma

United States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
Hui Bu

Recruiting

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

Lung Cancer | Leptomeningeal Metastasis

China
National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore; Innogene Kalbiotech Pte...

Active, not recruiting

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

Carcinoma, Squamous Cell of Head and Neck

Philippines, Thailand, Korea, Republic of, Australia, Taiwan, India, Saudi Arabia, Singapore, South Africa, Egypt, Cuba, Indonesia, Malaysia
DOMCA S.A.

Completed

Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers.

Intestinal Bacteria Flora Disturbance

Spain
Cancer Institute and Hospital, Chinese Academy...

Unknown

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
National Center for Complementary and Integrative...
Office of Dietary Supplements (ODS)

Completed

Comparing Effects of 3 Sources of Garlic on Cholesterol Levels

Hypercholesterolemia

United States
Biogen

Completed

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Alzheimer's Disease

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

Pancreatic Cancer

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Pancreatic Cancer

China
DOMCA S.A.

Completed

Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels

Cardiovascular Health

Spain
Xijing Hospital

Not yet recruiting

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

Head and Neck Squamous Cell Carcinoma
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Not yet recruiting

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice (FIL_MAB)

Non-Hodgkin Lymphoma, B-cell

Italy
The First Affiliated Hospital of Soochow University
Biotech Pharmaceutical Co., Ltd.; Cinda Biopharmaceutical (Suzhou) Co., Ltd.

Not yet recruiting

Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (Carpp-1)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and...
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients (NSCLC)

Non-small Cell Lung Cancer

China
Nicola Goekbuget

Recruiting

Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

Precursor Cell Lymphoblastic Leukemia

Germany
Drexel University College of Medicine

Completed

A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas

Gliomas

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)

Lymphoma, B-Cell

Search clinical trials for: mAb Nimotuzumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations